spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Cambridge Sensotec (manufacturers of Dynascan) obtains new ISO accreditation

Dynascan


The certification shows that our quality policy, quality management and operating systems, merit the requirements of this UKAS accredited international standard. Cambridge Sensotec is delighted to be recognised for displaying such high levels of standards.

Increasingly in this global market place, organisations need to be able to demonstrate sound management that is orientated towards the customer. ISO’s 9001:2015 and its risk-based approach, provides a solid framework for meeting customer challenges and provide the foundation to long term sustainability and profitability within the organisation.

Quality Management System (QMS) enables an organisation to have confidence in the products and services it provides to its customers. QMS acts as a platform to ensure consistency, efficiency and traceability as well as promoting best practice, improving customer service and satisfaction in key areas like delivery times, quality and service.

To view or download our certificate, please click here.

phone +44 (0)1480 462142
email info@dynascan.co.uk
web www.dynascan.co.uk
email 29 Stephenson Road, St Ives, Cambridgeshire PE27 3WJ
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Arcis Biotechnology appointments Professor Steve Howell as Non-Executive Chairman

Daresbury, UK, 24 July 2019: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced it has appointed Professor Steve Howell as Non-Executive Chairman of its Board of Directors. Steve takes over the position from Paul Foulger, who was serving as Chairman on an interim basis on behalf of the Board.
More info >>


White Papers

Characterisation of Biopharmaceutical Proteins

Reading Scientific Services Ltd (RSSL)

Over the next five years it is anticipated that there is going to be an explosion in the numbers of biosimilar products coming to market as patents expire. Consequently, in line with regulatory guidance, there will be a commensurate need to provide full characterisation of such biopharmaceuticals. The purpose of this article is to describe the array of the more common techniques used in biopharmaceutical characterisation (typically of protein or polypeptide). For full characterisation of a protein, the protein�s primary, secondary and tertiary structure as well as its physiochemical properties should be assessed.
More info >>

Industry Events

World Vaccine Congress Europe

28-31 October 2019, Barcelona, Spain

The 20th annual World Vaccine Congress Europe is taking place 28-31 Oct in Barcelona. It’s the biggest and most established European vaccine event with over 250 speakers, 700+ senior vaccine attendees, hundreds of networking hours. It cover key topics across the complete vaccine value chain bringing together: • Government • big pharma • big biotech • SME Biotech • academia and the wider service provider community and their partners to discuss scientific, clinical and strategic advances and opportunities. The event has already confirmed over 200 speakers from Human Vaccine Project, OECD, CEPI, European Commission, FDA, WHO, OECD, NIH, GSK and many more… There is a Super Early Bird offer available – Find Out More www.terrapinn.com/WVCEU/EBR
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement